Cell Genesys, Japan Tobacco deal

CEGE and Japan Tobacco's JT Immunotech USA Inc. subsidiary extended for two years their collaboration to develop human monoclonal antibodies.

The 1991 agreement established Xenotech, a 50/50 joint venture, which provides research payments to CEGE to develop human antibody-producing mice. ...